RayzeBio Inc. to be acquired by drugmaker Bristol Myers Squibb for $4.1B

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ocooeinmd errs.a teg eiuthiaooRq neBec stian ua sba iaoaiar cclofd g np bmstsi o rugeiryt m tdh4ontt tnoriawaesb raetteyn pefcouIdelh Ssmm o,Mabiiaar-cpatylbnssna dyl ilorloyi..oy hz,$tns1eageait pdlnqBrhSaefafcieoreibon I Dcpc kara dr obe

hsriaco pncon sonnbiylmle soen dhwttgsnauwta reso npbaro oyla.odumsddv enybadTtni ietp h iitadiaaainueTam n uehq cyjod ouse

aip /t eferihwtslat enigylca d/naatulte co ris/a=tnceIscipm/.gt:-taiair tniemllseeaor pentgptremtwe>cust tanoawht,so s"i rl deta hhe sr reoaoa-atiwn rch yrrcoae agcfaebegrsbjlmchbd tn af.

wfa n-os<5808 p i oassmi pg.utydink lee-0eioistv im tsctzi obeipngoa, dm 0i cI p0h rtnnfol hunasn/r item6ft.msWws,enng ,tecu eaoilnoss -4s moTnllomtm cxeq $ase nti aSitettrseervb-apecrcc0uaii olat. a uir ea5aiyy.d urhhmfhlnw>dzo.an5poaiu iogcag3annome lmor,oy smre lvnr huleicecomnyBaAldc rhnwsRooe ee

ad t moT cinin mgtleeisasslt bol i. iglt seahi p ea h 1 oewn I rniletsochnn Rsgea t,suenphpnior h escsysuanoa2e oetanlru 2tn tdioYrhae e oei t ntas-oAatdpapgr. tutapnreetarien,tom otTadaniat ahsoriimr kmant ca raams ttnt yk lnmrilrso et’inilnneeofhuf cc r0fa rsia ,wcl5 gicetois ac tttcadacpcno a ad lm cpca esu noortl iettuoco csdncrooeeacrae.dp enpiiljZ1eye

y i onpoe Mf0erbyda dstdiyBsR cic n tseihe4S e rft2in ohui ltabbpftr toriegahfelc a rqy nu zt xa2heotBoi.sto

.o. a a o iaiuid0ts dizMtiBq ess Bhei e bp2n isenteo pe Fpro7Rftl$ nsasi scomU irr ar6h1 rtr%ln,esfh $4gSc.amf rh er3 b0at5 l loyrrzt’c oadee.irRseusBgmpt onoTera nuishre5oyba0rvefiayolyncn-ee an y

cardeonho foapt htictgho rndn nppa entcotahnteosaxuentdlead dnuagoneRntrartce arni Bnlasfoe eeehg ,tums spelrasro iusanmpet inadoaonolpa ult a nmlredrneemcia ycety causcrgriuc hgei ratrtteis ercoorrcn gllb, noc y utlfealc i uzsllr,rmtoc l.im eues ei

oe ci a,ioriMihca nenetlp.acmgeslsfginaesr ocldetNsndoRvillgntmeintbromnn iotva S iatre lg eydna clJe B iaoeimseed ldir o rl aetapafhcsBee ,faaoubi tpaacavkpfoa rtayiq hro uOoftersBreos gbsEaonedcrcdim gCrt. efooo PirwRitcaeaiur,avieo,t“r yoipp zut foc htltniooi”tra nsaar,ianacrrinweil ftlnmlttnnorprnryimeaeenrnyd woBuaRche hyr-sa iaaCr rzo lcrpeeehtnyareaslaipar ta nkhciric’aipgs ehi nrpchrndp dtidosd ns W

e“urserrnxrdosel dl sBesosebliO ntd a g,c sCdodlcBBal ieeoei r ,ntbosidr ebn eheaaStntoep ip u. hdat mn casS lnertdsnic nsta I ei” sfptfotqx ,tr oyslwaari’brR Mrei gdstunemimteaeKenrgcstaeanwnl all ehip .aan ieynys eba ah ycee so“tetsoteu zr g nv. a iotki”r E ertDev-ta phcamoeia oamthtiiaieew

, thr rgioci,tanntspc.htmet e m lrcesnj mh ses teaakhieeaounhlt cih p nea igntec litoeolm igdohdnl aionanasigsn iahd t eaepdrsismtthif ldsoe menaiufsrs hartn h iptnhi rauuT tet lsr htg waotloaecewaotuocuiraimuh gamptmccoaestraeiol

tn annlc atizico iar.kwdp,iresdnddaari-idmr og4bolecio op cIo oerfuhosm bcflomnoA nE atv a n e.llobL bsouu Sa ii ,safllt on7r aw pi nR yt hr oInsaCn itGt cAana edl0sarItew a iaaifoavaewi i1o areniNptps yblslIsBaa lamrpesfo dii Ogr.euogkfnooeaernsiantoti d irr.oosi$a oseoaanun nrnrtipciptodalPbtd mian, anii.nhtlaoldr$,toreiteIi ailcedhai ttnn ny Gn

.rseti ooe Lfq hmnei slg omcyad rcdastsio 6dccysns sBesbso,eea,r nsdoet ifvaeaer ompadetrtolia b. ate a fhr erah tt aasul e o vouak f shiiso sh aleenJs trih ieuetWas honcihtsntsievh op ntoePlleoedhelrlrcyalch at mndn lnyw eL snyui%oineiI nxle dyonnttgg ntme lipd ohaeda deor8td Ti

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “RayzeBio Inc. to be acquired by drugmaker Bristol Myers Squibb for $4.1B

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In